Arushi Agarwal

ORCID: 0000-0003-0682-1822
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Metabolism, Diabetes, and Cancer
  • Cancer Risks and Factors
  • Heat shock proteins research
  • Esophageal and GI Pathology
  • Cancer, Hypoxia, and Metabolism
  • Testicular diseases and treatments
  • Prenatal Screening and Diagnostics
  • Pharmaceutical studies and practices
  • Folate and B Vitamins Research
  • Chronic Lymphocytic Leukemia Research
  • Platelet Disorders and Treatments
  • Neonatal and Maternal Infections
  • Neutropenia and Cancer Infections
  • Congenital Diaphragmatic Hernia Studies
  • Celiac Disease Research and Management
  • Neonatal Health and Biochemistry
  • Muscle and Compartmental Disorders
  • Enzyme Structure and Function
  • Blood groups and transfusion
  • Urological Disorders and Treatments
  • Nursing Roles and Practices
  • Hernia repair and management

Rajiv Gandhi Cancer Institute and Research Centre
2018-2024

Icahn School of Medicine at Mount Sinai
2024

Institute of Cytology and Preventive Oncology
2023

Stanford University
2021-2022

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
2016-2017

Among men, prostate cancer is the second leading cause of cancer-associated mortality, with advanced disease remaining a major clinical challenge. We describe small molecule, SU086, as therapeutic strategy for cancer. demonstrate that SU086 inhibits growth cells in vitro, cell-line and patient-derived xenografts vivo, ex vivo patient specimens. Furthermore, combination standard care second-generation anti-androgen therapies displays increased impairment cell tumor vitro vivo. Cellular...

10.1016/j.xcrm.2021.100502 article EN cc-by-nc-nd Cell Reports Medicine 2022-02-01

Aim . Congenital lumbar hernia is an uncommon anomaly with only few cases reported in the English literature. This study was done to incidence, age at presentation, sex, associated anomalies, surgical management, and postoperative morbidity mortality of congenital pediatric patients. Methods Retrospective analysis all patients CLH over a period 15 years (January 2000 December 2015) analyzed. Results A total 14 were encountered this series. All presented within first 2 age. 12 males females....

10.1155/2016/7162475 article EN cc-by International Journal of Pediatrics 2016-01-01

Introduction. Congenital anomalies are important causes of childhood death, chronic illness, and disability in many countries. malformations rapidly emerging as one the major worldwide problems. Aim. To study percentage various congenital among patients admitted Department Pediatric Surgery at a tertiary care centre over period four years from 2011 to 2015 our centre. Results. Neural tube defects were found be most common 24.3% children admitted. Other anorectal malformation (20.7%),...

10.1155/2017/4174573 article EN cc-by International Journal of Pediatrics 2017-01-01

Background: Metabolic syndrome (MetSyn) is an important late effect of childhood cancer. The combination rising obesity and high prevalence under-nutrition at diagnosis, make this a unique population to study in LMIC (lower middle-income countries). Method: Children <18 years age cancer single-centre LMIC, who were disease free had completed treatment least 2 prior included. MetSyn was defined using International Federation for Diabetes criteria Asian Indians. Univariate multivariable...

10.22541/au.170665032.24886312/v1 preprint EN Authorea (Authorea) 2024-01-30

Among men, prostate cancer is the second leading cause of cancer-associated mortality, with advanced disease remaining a major clinical challenge. We describe small molecule, SU086, as new therapeutic strategy for cancer. demonstrate that SU086 inhibits growth cells in vitro, cell line and patient-derived xenografts vivo, ex vivo patient specimens. Furthermore, combination standard care second-generation anti-androgen therapies displayed increased impairment tumor vitro vivo. Cellular...

10.2139/ssrn.3869894 article EN SSRN Electronic Journal 2021-01-01

Despite the absence of thyroid disease, patients with non-thyroidal illness (NTI) frequently have changes in serum levels hormones that may suggest dysfunction. One such is neonatal sepsis. C-reactive protein (CRP) a marker Levels free are reduced septic neonates. That's why we conducted this study, which FT3 and FT4 were measured along CRP 25 sick neonates controls similar weight gestational age. It was observed lower having high levels. also concluded low correlate poor prognosis

10.5958/0976-5506.2016.00155.8 article EN Indian Journal of Public Health Research & Development 2016-01-01

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. There can be multiple underlying causes which need to addressed. Helicobacter pylori (H.pylori) infection one such cause, but there paucity of data support its association with newly diagnosed ITP in children. We report a case child Down syndrome Graves' disease who initially presented pancytopenia, later developed were possible etiologies including Parvovirus B19 resulted delay treatment our...

10.1016/j.phoj.2023.07.002 article EN cc-by-nc-nd Pediatric Hematology Oncology Journal 2023-07-05

Please see fulltext.

10.21699/jns.v6i2.466 article EN Journal of Neonatal Surgery 2017-04-15

Abstract Purpose Metabolic syndrome (MetSyn) is an important late effect of childhood cancer. The combination rising obesity and high prevalence under-nutrition at diagnosis, make this a unique population to study in LMIC (lower middle-income countries). Methods Children < 18 years age cancer single-centre LMIC, who were disease free had completed treatment least 2 prior included. MetSyn was defined using International Federation for Diabetes criteria Asian Indians. Logistic regression...

10.21203/rs.3.rs-747126/v1 preprint EN cc-by Research Square (Research Square) 2021-09-20
Coming Soon ...